KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to 0.09%.

  • Neogenomics' Return on Capital Employed fell 200.0% to 0.09% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.09%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.08% for FY2025, which is 100.0% down from last year.
  • Per Neogenomics' latest filing, its Return on Capital Employed stood at 0.09% for Q4 2025, which was down 200.0% from 0.09% recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' Return on Capital Employed peaked at 0.02% during Q2 2021, and registered a low of 0.1% during Q3 2022.
  • Its 5-year average for Return on Capital Employed is 0.07%, with a median of 0.07% in 2024.
  • Per our database at Business Quant, Neogenomics' Return on Capital Employed tumbled by -800bps in 2022 and then soared by 300bps in 2023.
  • Quarter analysis of 5 years shows Neogenomics' Return on Capital Employed stood at 0.07% in 2021, then tumbled by -44bps to 0.1% in 2022, then grew by 28bps to 0.07% in 2023, then decreased by -1bps to 0.07% in 2024, then tumbled by -32bps to 0.09% in 2025.
  • Its Return on Capital Employed was 0.09% in Q4 2025, compared to 0.09% in Q3 2025 and 0.08% in Q2 2025.